Welcome to our dedicated page for M Evo Global Acquisition II news (Ticker: MEVOU), a resource for investors and traders seeking the latest updates and insights on M Evo Global Acquisition II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect M Evo Global Acquisition II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of M Evo Global Acquisition II's position in the market.
M Evo Global Acquisition Corp II (Nasdaq: MEVO) announced that, effective February 19, 2026, holders of units sold in its February 2, 2026 IPO may elect to separately trade the Class A ordinary shares and warrants on the Nasdaq Global Market.
Each unit contains one Class A ordinary share and one-half of one redeemable warrant (exercise price $11.50). Separated shares will trade as MEVO and whole warrants as MEVOW; unsplit units remain MEVOU. No fractional warrants will be issued, and holders must instruct brokers to contact the transfer agent to separate units.
M EVO GLOBAL ACQUISITION CORP II (NYSE: MEVO) closed its initial public offering of 30,000,000 units at $10.00 per unit, including 3,000,000 units from full over-allotment, generating $300,000,000 in gross proceeds.
Units began trading on the Nasdaq Global Market under MEVOU on January 30, 2026. Each unit includes one Class A share and one-half warrant (warrant exercise price $11.50). The company intends to target business combinations in the critical minerals sector relevant to U.S. economic and national security interests.
M EVO GLOBAL ACQUISITION CORP II (NASDAQ:MEVO) priced an upsized initial public offering of 27,000,000 units at $10.00 per unit, representing gross proceeds of approximately $270 million. Trading of units began under MEVOU on January 30, 2026.
Each unit includes one Class A ordinary share and one-half warrant (full warrant exercisable at $11.50). Class A shares and warrants are expected to trade as MEVOX and MEVOW when separated. The offering is expected to close February 2, 2026, with Cohen & Company Capital Markets as book-running manager and a 45-day option to purchase up to 3,000,000 additional units. The SPAC intends to target businesses in the critical minerals sector.